DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hiroishi K, Eguchi J, Baba T. , et al.
Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
J Gastroenterol 2010;
45 (04) 451-458
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.